{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1381699994450054913.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Hirotaka Nakayama"}],"foaf:familyName":[{"@value":"Nakayama"}],"foaf:givenName":[{"@value":"Hirotaka"}]}],"career":[{"institution":{"notation":[{"@value":"Mingzhao Xing and Ali S. Alzahrani, Johns Hopkins University School of Medicine; Kathryn A. Carson, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD; Young Kee Shong and Tae Yong Kim, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; David Viola and Rossella Elisei, WHO Collaborating Center for the Study and Treatment of Thyroid Diseases and Other Endocrine and Metabolic Disorders, University of Pisa, Pisa; Caterina Mian, University of Padua;..."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1361699994450054784","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1200/jco.2014.56.8253"},{"@type":"URI","@value":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2014.56.8253"}],"notation":[{"@value":"Association Between <i>BRAF</i> V600E Mutation and Recurrence of Papillary Thyroid Cancer"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1200/jco.2014.56.8253_Ky1Wj5m1nHsFMzXgVuIgBwyZIJS"}]}